V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10456373 | 10034614 | 1.78 | 101.8 | Palliative (P) | 2016-03-14 | 2016-03-15 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101759462 |
| 10456410 | 10034615 | 1.67 | 66 | Palliative (P) | 2017-08-07 | 2017-09-05 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100960923 |
| 10456428 | 10034617 | 1.45 | 80.7 | null | 2020-05-16 | 2020-05-16 | CAPECITABINE + OXALIPLATIN | 02 | null | RITUXIMAB | 100643695 |
| 10456445 | 10034618 | 1.8 | 92.3 | Curative (C) | 2017-02-09 | 2017-02-21 | Capecitabine + Oxaliplatin 14day | 02 | N | PEMBROLIZUMAB | 100264422 |
| 10456471 | 10034619 | 1.88 | 101 | 03 | null | 2017-07-06 | Rituximab | 02 | N | RITUXIMAB | 100361146 |
| 10456473 | 10034620 | 1.74 | 71 | Palliative (P) | null | null | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100545561 |
| 10456477 | 10034621 | 1.71 | 99.3 | Curative (C) | 2018-10-26 | 2018-11-10 | Capecitabine + Oxaliplatin 21day | 02 | N | IBRUTINIB | 100379711 |
| 10456495 | 10034622 | 1.81 | 0 | null | 2019-10-23 | 2019-10-23 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100602825 |
| 10456503 | 10034623 | null | 67.5 | Adjuvant (A) | 2016-12-26 | 2017-01-06 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100269275 |
| 10456504 | 10034624 | null | 90 | Palliative (P) | 2019-09-10 | 2019-09-13 | Rituximab | 02 | N | RITUXIMAB | 100159826 |
| 10456506 | 10034625 | null | null | null | 2019-06-28 | 2019-07-10 | Rituximab | 99 | null | RITUXIMAB | 101217331 |
| 10456514 | 10034626 | null | 71.1 | Curative (C) | 2020-08-07 | 2020-08-25 | IBRUTINIB | 02 | N | IBRUTINIB | 101088910 |
| 10456530 | 10034627 | 1.68 | 93.7 | Adjuvant (A) | 2017-01-27 | 2017-01-28 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100949433 |
| 10456564 | 10034628 | 1.47 | null | 03 | 2019-09-13 | 2019-09-13 | CAPECITABINE + OXALIPLATIN | 02 | N | RITUXIMAB | 100313463 |
| 10456567 | 10034629 | 1.59 | 104.6 | Palliative (P) | 2016-08-01 | 2016-08-05 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100292970 |
| 10456568 | 10034630 | null | 100.6 | 03 | 2019-10-21 | 2019-10-22 | CHOP R - 21 days | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101461499 |
| 10456596 | 10034631 | 1.67 | 65.2 | Adjuvant (A) | 2020-03-10 | 2020-03-22 | CAPECITABINE + OXALIPLATIN | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101069351 |
| 10456682 | 10034632 | 1.67 | 91 | Palliative (P) | 2017-12-31 | 2018-01-09 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100551887 |
| 10456685 | 10034633 | 1.68 | 63 | Palliative (P) | 2021-03-25 | 2021-04-01 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100232350 |
| 10456696 | 10034634 | 1.74 | 101 | Neo-adjuvant (N) | 2016-12-03 | 2016-12-06 | Capecitabine + Oxaliplatin 21day | 02 | Y | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101698212 |
| 10456738 | 10034635 | 1.7 | 88 | Adjuvant (A) | 2020-10-17 | 2020-11-02 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 101112497 |
| 10456749 | 10034636 | 1.78 | 50.5 | Adjuvant (A) | 2020-02-02 | 2020-02-02 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101255826 |
| 10456756 | 10034637 | null | 80 | Palliative (P) | 2018-06-06 | 2018-06-07 | Rituximab | 02 | N | RITUXIMAB | 101852929 |
| 10456793 | 10034638 | 1.58 | 70.4 | Adjuvant (A) | 2019-11-21 | 2019-11-21 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100417572 |
| 10456805 | 10034639 | 1.8 | 88.4 | Palliative (P) | 2018-01-11 | 2018-02-01 | Docetaxel | 02 | N | DOCETAXEL | 101062548 |
| 10456816 | 10034640 | 1.68 | 84.8 | Neo-adjuvant (N) | 2016-05-21 | 2016-05-29 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100829828 |
| 10456820 | 10034641 | 1.64 | 44.2 | 02 | 2018-10-29 | 2018-12-09 | CAPECITABINE + OXALIPLATIN | 02 | N | RITUXIMAB | 100914946 |
| 10456833 | 10034642 | 1.67 | 76.8 | null | 2021-08-26 | 2021-09-04 | Capecitabine 35days + RT | 02 | null | CAPECITABINE | 100567018 |
| 10456851 | 10034643 | 1.66 | 106 | Palliative (P) | 2018-04-23 | 2018-05-02 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 101113906 |
| 10456879 | 10034644 | 1.49 | 58 | Curative (C) | 2017-11-21 | 2017-11-28 | Rituximab | 02 | N | RITUXIMAB | 101061859 |
| 10456896 | 10034645 | 1.66 | 75.2 | Palliative (P) | 2020-07-19 | 2020-07-20 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100985386 |
| 10456900 | 10034646 | 1.78 | 113.85 | 03 | 2021-04-19 | 2021-04-25 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101284297 |
| 10456904 | 10034647 | 1.69 | 88.2 | Palliative (P) | 2018-11-05 | 2018-11-05 | Capecitabine | 02 | N | CAPECITABINE | 101368202 |
| 10456925 | 10034648 | 1.67 | 97.2 | Curative (C) | 2019-05-16 | 2019-05-29 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | RITUXIMAB | 100835158 |
| 10456938 | 10034649 | 1.66 | 78.8 | Palliative (P) | 2018-09-20 | 2018-09-21 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 100665120 |
| 10456951 | 10034650 | 1.8 | 0 | Palliative (P) | 2017-11-15 | 2017-11-15 | Rituximab | 02 | N | RITUXIMAB | 101447391 |
| 10456971 | 10034651 | 1.77 | 74.8 | Adjuvant (A) | 2017-01-26 | 2017-01-26 | Rituximab | 02 | N | RITUXIMAB | 101260399 |
| 10456979 | 10034652 | 0 | 95 | Curative (C) | 2013-10-15 | 2016-08-01 | IBRUTINIB | 02 | N | IBRUTINIB | 100314311 |
| 10456983 | 10034653 | 1.65 | 48.8 | null | 2019-04-14 | 2019-04-14 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100558735 |
| 10456991 | 10034654 | 0 | 0 | Curative (C) | 2016-07-31 | 2016-08-03 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101567254 |
| 10457004 | 10034655 | 1.71 | 75 | Curative (C) | 2021-02-05 | 2021-02-05 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100282304 |
| 10457046 | 10034656 | 1.47 | 89.1 | null | 2017-10-04 | 2017-10-07 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100173129 |
| 10457056 | 10034657 | 1.55 | null | null | 2019-10-28 | 2019-12-16 | Docetaxel | 02 | null | DOCETAXEL | 101289157 |
| 10457066 | 10034658 | 1.62 | 72.9 | null | 2016-06-09 | 2021-12-21 | IBRUTINIB | 02 | null | IBRUTINIB | 100279929 |
| 10457081 | 10034659 | 1.78 | 74 | 03 | 2019-01-14 | 2019-01-23 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101822764 |
| 10457088 | 10034660 | null | 48 | Palliative (P) | 2022-05-30 | 2022-05-30 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 100108031 |
| 10457098 | 10034661 | 0 | 96.1 | Disease modification (D) | 2017-01-20 | 2017-02-20 | Rituximab | 02 | N | RITUXIMAB | 101719413 |
| 10457100 | 10034662 | 1.56 | 105.75 | null | 2020-08-23 | 2020-09-20 | Docetaxel | 02 | null | DOCETAXEL | 100026432 |
| 10457111 | 10034663 | 1.76 | 69.45 | Curative (C) | 2020-02-06 | 2020-02-07 | Capecitabine | 02 | N | CAPECITABINE | 100361092 |
| 10457124 | 10034664 | 1.67 | 60 | Palliative (P) | 2017-03-19 | 2017-04-10 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100334633 |